GleamWall
中文EN

GSK GSK plc IFRS Annual reports only

Pharmaceutical Preparations · NYSE · SEC CIK 1131399 · Reporting currency GBP

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY4.1%
TTM net income YoY122.0%
TTM EPS YoY123.2%
Revenue 3-yr CAGR3.7%
Net income 3-yr CAGR-27.4%

Margins

Gross margin72.4%
Operating margin24.3%
Net margin17.5%
FCF margin19.6%
EBITDA margin31.4%

Returns

ROE38.0%
ROA9.5%
ROIC (approx.)23.4%
Asset turnover0.54x

Leverage & solvency

Liabilities / assets73.9%
Debt / equity1.08x
Current ratio0.82x
Interest coverage11.32x

Cash quality & payout

Operating cash flow / net income1.35x
Accruals ratio-3.4%
Payout ratio44.9%
Capex / revenue4.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Unit: GBP FY20252025-12-31FY20242024-12-31
Income statement
Revenue32.67B31.38B
Cost of revenue9.02B9.05B
Gross profit23.65B22.33B
R&D expense7.53B6.40B
SG&A expense9.09B11.02B
Operating income7.93B4.02B
Interest expense701.00M669.00M
Pretax income7.40B3.48B
Income tax1.11B526.00M
Net income5.72B2.58B
EBITDA10.25B6.57B
EPS (basic)1.410.63
EPS (diluted)1.390.62
Weighted avg. shares (diluted)4.12B4.14B
Balance sheet
Cash & equivalents3.40B3.87B
Receivables7.47B6.84B
Inventory5.92B5.67B
Current assets17.51B17.00B
PP&E, netmay include right-of-use assets (IFRS)9.32B9.23B
Goodwill7.02B6.98B
Intangibles16.75B15.52B
Total assets61.12B59.46B
Current liabilities21.39B21.70B
Short-term debt3.01B2.35B
Long-term debt14.71B14.64B
Total debt17.72B16.99B
Total liabilities45.16B46.38B
Shareholders' equity16.38B13.67B
Net debt14.32B13.12B
Cash flow statement
Operating cash flow7.74B6.55B
Capital expenditure1.35B1.40B
Free cash flow6.39B5.16B
Investing cash flow-4.23B-1.23B
Financing cash flow-3.69B-4.73B
Depreciation & amortization2.31B2.55B
Stock-based compensation374.00M344.00M
Dividends paid2.56B2.44B
Share buybacks1.38B0

Free plan shows the latest 2 periods; Pro shows all 11 🔒

· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· Amounts are in the company's reporting currency, GBP, not USD; the site does no currency conversion.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.